Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal death

Experimental and Translational Stroke Medicine

Volumn 2, Issue 1, 2010, Pages

  Thundyil, John ^a   Tang, Sung Chun ^b   Okun, Eitan ^c   Shah, Kausik ^d   Karamyan, Vardan T ^d   Li, Yu I ^b   Woodruff, Trent M ^a   Taylor, Stephen M ^a   Jo, Dong Gyu ^e   Mattson, Mark P ^c   Arumugam, Thiruma V ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^e Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; CARBON DIOXIDE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OXYGEN;

ADULT; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATMOSPHERE; BRAIN CELL; BRAIN ISCHEMIA; BRAIN TISSUE; CASE REPORT; CONTROLLED STUDY; DISEASE EXACERBATION; EMBRYO; HUMAN; HUMAN EXPERIMENT; IMMUNOBLOTTING; IMMUNOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEOCORTEX; NERVE CELL NECROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 78751564907     PISSN: None     EISSN: 20407378     Source Type: Journal    
DOI: 10.1186/2040-7378-2-15     Document Type: Article

References (34)

1. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001, 98:2005-2010. 10.1073/pnas.041591798, 29372, 11172066.
2. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006, 116:1784-1792. 10.1172/JCI29126, 1483172, 16823476.
3. Ogunwobi OO, Beales IL. Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Mol Cell Endocrinol 2008, 285:43-50. 10.1016/j.mce.2008.01.023, 18313838.
4. Asada K, Yoshiji H, Noguchi R, Ikenaka Y, Kitade M, Kaji K, Yoshii J, Yanase K, Namisaki T, Yamazaki M, Tsujimoto T, Akahane T, Uemura M, Fukui H. Crosstalk between high-molecular-weight adiponectin and T-cadherin during liver fibrosis development in rats. Int J Mol Med 2007, 20:725-729.
5. Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, Yamaguchi M, Namiki S, Nakayama R, Tabata M, Ogata H, Kubota N, Takamoto I, Hayashi YK, Yamauchi N, Waki H, Fukayama M, Nishino I, Tokuyama K, Ueki K, Oike Y, Ishii S, Hirose K, Shimizu T, Touhara K, Kadowaki T. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 2010, 464:1313-1319. 10.1038/nature08991, 20357764.
6. Wanninger J, Neumeier M, Weigert J, Bauer S, Weiss TS, Schäffler A, Krempl C, Bleyl C, Aslanidis C, Schölmerich J, Buechler C. Adiponectin-stimulated CXCL8 release in primary human hepatocytes is regulated by ERK1/ERK2, p38 MAPK, NF-kappaB, and STAT3 signaling pathways. Am J Physiol Gastrointest Liver Physiol 2009, 297:G611-618. 10.1152/ajpgi.90644.2008, 19608729.
7. Tang CH, Lu ME. Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF-kappaB pathways. The Prostate 2009, 69:1781-1789. 10.1002/pros.21029, 19676095.
8. Guillod-Maximin E, Roy AF, Vacher CM, Aubourg A, Bailleux V, Lorsignol A, Pénicaud L, Parquet M, Taouis M. Adiponectin receptors are expressed in hypothalamus and colocalized with proopiomelanocortin and neuropeptide Y in rodent arcuate neurons. J Endocrinol 2009, 200:93-105. 10.1677/JOE-08-0348, 18971219.
9. Psilopanagioti A, Papadaki H, Kranioti EF, Alexandrides TK, Varakis JN. Expression of adiponectin and adiponectin receptors in human pituitary gland and brain. Neuroendocrinology 2009, 89:38-47. 10.1159/000151396, 18698133.
10. Li J, Zeng Z, Viollet B, Ronnett GV, McCullough LD. Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke. Stroke 2007, 38:2992-2999. 10.1161/STROKEAHA.107.490904, 2637379, 17901380.
11. Piao CS, Kim JB, Han PL, Lee JK. Administration of the p38 MAPK inhibitor SB203580 affords brain protection with a wide therapeutic window against focal ischemic insult. J Neurosci Res 2003, 73:537-544. 10.1002/jnr.10671, 12898538.
12. Yatomi K, Miyamoto N, Komine-Kobayashi M, Liu M, Oishi H, Arai H, Hattori N, Urabe T. Pathophysiological dual action of adiponectin after transient focal ischemia in mouse brain. Brain Res 2009, 1297:169-176. 10.1016/j.brainres.2009.08.039, 19699724.
13. Okun E, Arumugam TV, Tang SC, Gleichmann M, Albeck M, Sredni B, Mattson MP. The organotellurium compound ammonium trichloro(dioxoethylene-0,0') tellurate enhances neuronal survival and improves functional outcome in an ischemic stroke model in mice. J Neurochem 2007, 102:1232-1241. 10.1111/j.1471-4159.2007.04615.x, 17542809.
14. Jeng JS, Huang KM, Ya YT, Yip PK. Acta Neurologica Taiwanica 2000, 9:311-316.
15. Mao X, Kikani CK, Riojas RA, Langlais P, Wang L, Ramos FJ, Fang Q, Christ-Roberts CY, Hong JY, Kim RY, Liu F, Dong LQ. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol 2006, 8:516-523. 10.1038/ncb1404, 16622416.
16. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006, 6:772-783. 10.1038/nri1937, 16998510.
17. Luo N, Liu J, Chung BH, Yang Q, Klein RL, Garvey WT, Fu Y. Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis. Diabetes 2010, 59:791-799. 10.2337/db09-1338, 20350970.
18. Wang JH, Lee CJ, Lee CC, Chen YC, Lee RP, Hsu BG. Fasting adiponectin is inversely correlated with metabolic syndrome in patients with coronary artery disease. Intern Med 2010, 49:739-747. 10.2169/internalmedicine.49.3093, 20424363.
19. Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH, Kim JB. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 2006, 55:2562-2570. 10.2337/db05-1322, 16936205.
20. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002, 8:1288-1295. 10.1038/nm788, 12368907.
21. Kleman AM, Yuan JY, Aja S, Ronnett GV, Landree LE. Physiological glucose is critical for optimized neuronal viability and AMPK responsiveness in vitro. J Neurosci Methods 2008, 167:292-301. 10.1016/j.jneumeth.2007.08.028, 2257477, 17936912.
22. Nozaki K, Nishimura M, Hashimoto N. Mitogen-activated protein kinases and cerebral ischemia. Mol Neurobiol 2001, 23:1-19. 10.1385/MN:23:1:01, 11642541.
23. Barone FC, Irving EA, Ray AM, Lee JC, Kassis S, Kumar S, Badger AM, Legos JJ, Erhardt JA, Ohlstein EH, Hunter AJ, Harrison DC, Philpott K, Smith BR, Adams JL, Parsons AA. Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med Res Rev 2001, 21:129-145. 10.1002/1098-1128(200103)21:2<129::AID-MED1003>3.0.CO;2-H, 11223862.
24. Tang SC, Arumugam TV, Xu X, Cheng A, Mughal MR, Jo DG, Lathia JD, Siler DA, Chigurupati S, Ouyang X, Magnus T, Camandola S, Mattson MP. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci USA 2007, 104:13798-13803. 10.1073/pnas.0702553104, 1959462, 17693552.
25. Waki H, Yamauchi T, Kamon J, Kita S, Ito Y, Hada Y, Uchida S, Tsuchida A, Takekawa S, Kadowaki T. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 2005, 146:790-796. 10.1210/en.2004-1096, 15528304.
26. Nishimura M, Izumiya Y, Higuchi A, Shibata R, Qiu J, Kudo C, Shin HK, Moskowitz MA, Ouchi N. Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 2008, 117:216-23. 10.1161/CIRCULATIONAHA.107.725044, 18158361.
27. Arumugam TV, Granger DN, Mattson MP. Stroke and T-cells. Neuromolecular Med 2005, 7:229-242. 10.1385/NMM:7:3:229, 16247183.
28. Ishikawa M, Vowinkel T, Stokes KY, Arumugam TV, Yilmaz G, Nanda A, Granger DN. CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion. Circulation 2005, 111:1690-1696. 10.1161/01.CIR.0000160349.42665.0C, 15795333.
29. Haugen F, Drevon CA. Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin. Endocrinology 2007, 148:5478-86. 10.1210/en.2007-0370, 17702846.
30. Hattori Y, Hattori S, Kasai K. Globular Adiponectin Activates Nuclear Factor-κB in Vascular Endothelial Cells, Which in Turn Induces Expression of Proinflammatory and Adhesion Molecule Genes. Diabetes Care 2006, 29:139-141. 10.2337/diacare.29.01.06.dc05-1364, 16373912.
31. Tomizawa A, Hattori Y, Kasai K, Nakano Y. Adiponectin induces NF-κB activation that leads to suppression of cytokine-induced NF-κB activation in vascular endothelial cells: globular adiponectin vs. high molecular weight adiponectin. Diabetes and Vascular Disease Research 2008, 5:123-127. 10.3132/dvdr.2008.020, 18537100.
32. Bråkenhielm E, Veitonmäki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B, Funahashi T, Cao Y. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA 2004, 1018:2476-2481.
33. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257:79-83. 10.1006/bbrc.1999.0255, 10092513.
34. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001, 7:947-53. 10.1038/90992, 11479628.